Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /JAGSNPHARM

Jagsonpal Pharmaceuticals Ltd.

JAGSNPHARM

• NSE: JAGSNPHARM • Delayed

210.37INR 0.7%

2.20 USD

As of 5 June 2026, Jagsonpal Pharmaceuticals Ltd. has a market cap of $146.43M USD, ranking #23024 globally and #1342 in India. It ranks #2078 in the Healthcare sector, and #107 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

23024

Country Rank

1342

Sector Rank

2078

Industry Rank

107

Key Stats

Market Cap

$146.43MUSD

14.02B INR

Enterprise Value

$136.2MUSD

13.04B INR

Revenue (TTM)

$31.25MUSD

2.99B INR

EBITDA (TTM)

$7.32MUSD

700.69M INR

Net Income (TTM)

$4.5MUSD

430.82M INR

EBITDA Margin

23%

Profit Margin

14%

PE Ratio

33.1

PS Ratio

4.7

PB Ratio

5.1

EV/EBITDA

18.6

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Manish Gupta open_in_new

Employees

1,399

Founded

1978

Website

jagsonpal.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.7%	6.3%	13%	28%	-6.2%	8.4%	-10%	52%	434%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	JAGSNPHARM Jagsonpal Pharmaceuticals Ltd ISIN: INE048B01035 Shares Out.: Shares Outstanding: 67.139M¹ Shares Float: 15.582M² TV: TradingView: NSE: JAGSNPHARM SA: Stock Analysis: NSE: JAGSNPHARM YF: Yahoo Finance: JAGSNPHARM.NS GF: Google Finance: NSE: JAGSNPHARM BA: Barron's: JAGSNPHARM MS: Morningstar: XNSE: JAGSNPHARM	210.37 INR	TV: TradingView: NSE: JAGSNPHARM SA: Stock Analysis: NSE: JAGSNPHARM YF: Yahoo Finance: JAGSNPHARM.NS GF: Google Finance: NSE: JAGSNPHARM BA: Barron's: JAGSNPHARM MS: Morningstar: XNSE: JAGSNPHARM
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	507789 (JAGSNPHARM) Jagsonpal Pharmaceuticals Ltd ISIN: INE048B01035 TV: TradingView: BSE: JAGSNPHARM SA: Stock Analysis: BOM: 507789 YF: Yahoo Finance: 507789.BO GF: Google Finance: BOM: 507789 BA: Barron's: 507789 MS: Morningstar: XBOM: 507789	208.85 INR	TV: TradingView: BSE: JAGSNPHARM SA: Stock Analysis: BOM: 507789 YF: Yahoo Finance: 507789.BO GF: Google Finance: BOM: 507789 BA: Barron's: 507789 MS: Morningstar: XBOM: 507789

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Jagsonpal Pharmaceuticals Ltd.

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)

Name	Market Cap (USD) diff.	PE	Country
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 7K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 7K%	22.7	India
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.43B 807.02B INR 6K%	23.1	India
Cohance Lifesciences Ltd. NSE: SUVENPHAR	$1.87B 178.87B INR 1K%	199.0	India
Granules India Ltd. NSE: GRANULES	$1.83B 174.85B INR 1K%	32.1	India
Viyash Scientific Ltd. NSE: SEQUENT	$944.92M 90.48B INR 545%	92.7	India

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 26K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 20K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 11K%	16.0	China
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 6K%	80.6	China
ABIVAX Société Anonyme EPA: ABVX	$8.79B 7.57B EUR 6K%	-	France
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.22B 35.33B CNY 3K%	20.0	China

chevron_leftBack